Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

121. Is Shock Index a Valid Predictor of Mortality in Emergency Department Patients With Hypertension, Diabetes, High Age, or Receipt of beta- or Calcium Channel Blockers? (PubMed)

Is Shock Index a Valid Predictor of Mortality in Emergency Department Patients With Hypertension, Diabetes, High Age, or Receipt of beta- or Calcium Channel Blockers? Shock index is a widely reported tool to identify patients at risk for circulatory collapse. We hypothesize that old age, diabetes, hypertension, and β- or calcium channel blockers weaken the association between shock index and mortality.This was a cohort study of all first-time emergency department (ED) visits between 1995 (...) and 2011 (n=111,019). We examined whether age 65 years or older, diabetes, hypertension, and use of β- or calcium channel blockers modified the association between shock index and 30-day mortality.The 30-day mortality was 3.0%. For all patients, with shock index less than 0.7 as reference, a shock index of 0.7 to 1 had an adjusted odds ratio (OR) of 2.9 (95% confidence interval [CI] 2.7 to 3.2) for 30-day mortality, whereas shock index greater than or equal to 1 had an OR of 10.5 (95% CI 9.3 to 11.7

2015 EvidenceUpdates

122. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tam

Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tam Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha

2015 NIHR HTA programme

123. Calcium supplementation for prevention of primary hypertension. (PubMed)

Calcium supplementation for prevention of primary hypertension. Hypertension is a major public health problem that increases the risk of cardiovascular and kidney diseases. Several studies have shown an inverse association between calcium intake and blood pressure. As small reductions in blood pressure have been shown to produce rapid reductions in vascular disease risk even in individuals with normal blood pressure ranges, this review intends to evaluate the effect of calcium supplementation (...) in normotensive individuals as a preventive health measure.To assess the efficacy and safety of calcium supplementation versus placebo or control for reducing blood pressure in normotensive people.We searched the Cochrane Hypertension Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, EMBASE and ClinicalTrials.gov for randomised controlled trials up to October 2014. The WHO International Clinical Trials Registry Platform (ICTRP) is searched

Full Text available with Trip Pro

2015 Cochrane

124. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. (PubMed)

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. Antiretroviral therapy initiation for HIV-1 infection is associated with 2% to 6% loss of bone mineral density (BMD).To evaluate the effect of vitamin D3 plus calcium supplementation on bone loss associated with antiretroviral therapy initiation.48-week prospective, randomized, double-blind, placebo-controlled study. (ClinicalTrials.gov: NCT01403051).39 AIDS Clinical Trials Group units.Adults (...) with antiretroviral therapy-naive HIV.BMD by dual-energy x-ray absorptiometry, 25-hydroxyvitamin D levels, and other laboratory assessments.165 eligible patients were randomly assigned (79 received vitamin D3 plus calcium and 86 received placebo). The study groups were well-balanced at baseline: 90% were men, 33% were non-Hispanic black, and the median CD4 count was 0.341 × 109 cells/L. At 48 weeks, the percentage of decline in total hip BMD was smaller in the vitamin D3 plus calcium group than in the placebo

Full Text available with Trip Pro

2015 Annals of Internal Medicine Controlled trial quality: predicted high

125. Long-term Use of Acamprosate Calcium for Alcoholism

Long-term Use of Acamprosate Calcium for Alcoholism Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along with other (...) not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners? own terms and conditions. TITLE: Long-term Use of Acamprosate Calcium for Alcoholism: A Review of the Clinical

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

126. High-Protein Diet Without Increased Calcium Intake Can Lead to Ridge Resorption and Osteoporosis in Women

High-Protein Diet Without Increased Calcium Intake Can Lead to Ridge Resorption and Osteoporosis in Women UTCAT2893, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title High-Protein Diet Without Increased Calcium Intake Can Lead to Ridge Resorption and Osteoporosis in Women Clinical Question How does a high protein diet affect ridge resorption in women? Clinical Bottom Line A high protein diet coupled with a low calcium (...) intake can increase urinary losses of calcium and is linked to osteoporosis and ridge resorption in older women. This is supported by narrative reviews outlining observations of populations who maintain a high protein diet and a narrative review of studies showing the relationship between increased protein intake and increased levels of calcium lost in urine. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence

2015 UTHSCSA Dental School CAT Library

127. Additive Prognostic Value of Coronary Artery Calcium Score Over Coronary Computed Tomographic Angiography Stenosis Assessment in Symptomatic Patients Without Known Coronary Artery Disease (PubMed)

Additive Prognostic Value of Coronary Artery Calcium Score Over Coronary Computed Tomographic Angiography Stenosis Assessment in Symptomatic Patients Without Known Coronary Artery Disease The objective of this study was to examine the additive prognostic performance of coronary artery calcium score (CACS) over coronary computed tomography angiography (CCTA) stenosis assessment in symptomatic patients suspected for coronary artery disease (CAD) undergoing CCTA. A total of 805 symptomatic

2015 EvidenceUpdates

128. Oral Calcium Supplementation Does Not Increase Risk of Calcium Nephrolithiasis in Postmenopausal Women

Oral Calcium Supplementation Does Not Increase Risk of Calcium Nephrolithiasis in Postmenopausal Women "Oral Calcium Supplementation Does Not Increase Risk of Calcium Nephrol" by Wei Kuang < > > > > > Title Author Date of Graduation Summer 8-8-2015 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Mary E. Von, DHEd, PA-C, DFAAPA Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: The American Association of Clinical (...) Endocrinologists (AACE) current recommendation is 1000-1200 mg calcium daily for postmenopausal and osteoporotic women. Some patients are reluctant to supplement calcium due to the fear of developing a kidney stone (nephrolithiasis). In the United States, every adult will have a 10% to 15% chance to get kidney stones in their lifetime. And the recurrence rate is up to 50% after 10 years. There is no clear theory on how kidney stones are formed. There are lots of factors that play into the role of kidney stone

2015 Pacific University EBM Capstone Project

129. Randomised controlled trial: ?-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location

Randomised controlled trial: ?-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location α-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more (...) about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here α-channel and calcium-channel blockers are ineffective as medical expulsive therapy

2015 Evidence-Based Medicine (Requires free registration)

130. Natpara (parathyroid horomone) - To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism

Natpara (parathyroid horomone) - To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Natpara (parathyroid hormone) Company: NPS Pharmaceuticals Inc. Application No.: 125511 Approval Date: 1/23/2015 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF

2015 FDA - Drug Approval Package

131. Vitamin D and calcium: a systematic review of health outcomes (update)

Vitamin D and calcium: a systematic review of health outcomes (update) Vitamin D and calcium: a systematic review of health outcomes (update) Vitamin D and calcium: a systematic review of health outcomes (update) Newberry SJ, Chung M, Shekelle PG, Booth MS, Liu JL, Maher AR, Motala A, Cui M, Perry T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation Newberry SJ, Chung M, Shekelle PG, Booth MS, Liu JL, Maher AR, Motala A, Cui M, Perry T. Vitamin D and calcium: a systematic review of health outcomes (update) Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 217. 2014 Authors' objectives To systematically summarize the evidence on the relationship between vitamin D alone or in combination with calcium on selected health outcomes included in the earlier review: primarily those related

2014 Health Technology Assessment (HTA) Database.

132. Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation

Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation TITLE: Dioctyl Sulfosuccinate or Docusate (Calcium or Sodium) for the Prevention or Management of Constipation: A Review of the Clinical Effectiveness DATE: 26 June 2014 CONTEXT AND POLICY ISSUES Constipation has many definitions and is often described differently depending on the population queried. Many physicians define constipation as a reduction in the frequency of bowel movements (...) or bulking agents (i.e. psyllium seed husk), osmotic laxatives (i.e. lactulose, sorbitol, polyethylene glycol [PEG]), stimulant laxatives (i.e. sennosides, bisacodyl, sodium picosulfate), and stool softeners (i.e. docusate sodium or calcium). 1,2 In North America, docusate and a stimulant laxative such as sennosides are commonly used in bowel treatment protocols associated with institutionalized elderly 4 and oncology treatments. 5 A paucity of evidence is available to support the use of the stool

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

133. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. (PubMed)

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Pre-eclampsia and eclampsia are common causes of serious morbidity and death. Calcium supplementation may reduce the risk of pre-eclampsia, and may help to prevent preterm birth.To assess the effects of calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child outcomes.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (...) (28 March 2013) and contacted study authors for more data where possible. We updated the search in May 2014 and added the results to the 'Awaiting Classification' section of the review.Randomised controlled trials (RCTs) comparing high-dose (at least 1 g daily of calcium) or low-dose calcium supplementation during pregnancy with placebo or no calcium.We assessed eligibility and trial quality, extracted and double-entered data.High-dose calcium supplementation (≥1 g/day)We included 14 studies

Full Text available with Trip Pro

2014 Cochrane

134. Calcium channel blockers for inhibiting preterm labour and birth. (PubMed)

Calcium channel blockers for inhibiting preterm labour and birth. Preterm birth is a major contributor to perinatal mortality and morbidity, affecting around 9% of births in high-income countries and an estimated 13% of births in low- and middle-income countries. Tocolytics are drugs used to suppress uterine contractions for women in preterm labour. The most widely used tocolytic are the betamimetics, however, these are associated with a high frequency of unpleasant and sometimes severe (...) maternal side effects. Calcium channel blockers (CCBs) (such as nifedipine) may have similar tocolytic efficacy with less side effects than betamimetics. Oxytocin receptor antagonists (ORAs) (e.g. atosiban) also have a low side-effect profile.To assess the effects on maternal, fetal and neonatal outcomes of CCBs, administered as a tocolytic agent, to women in preterm labour.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (12 November 2013).All published and unpublished

Full Text available with Trip Pro

2014 Cochrane

135. Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial (PubMed)

Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial To determine whether children with calcium-deficiency rickets have a better response to treatment with vitamin D and calcium than with calcium alone.Randomised controlled trial.Jos University Teaching Hospital, Jos, Nigeria.Nigerian children with active rickets treated with calcium carbonate as limestone (approximately 938 mg elemental calcium twice daily) were, in addition, randomised to receive either oral (...) (56.4±17.2 nmol/L) than in those who did not (37.7±18.5 nmol/L, p<0.001).In children with calcium-deficiency rickets, there is a trend for vitamin D to improve the response to treatment with calcium carbonate as limestone, independent of baseline 25(OH)D concentrations.ClinicalTrials.gov NCT00949832.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Full Text available with Trip Pro

2014 EvidenceUpdates Controlled trial quality: predicted high

136. Fortification of Juices with Calcium Helps Decrease the Risk of Dental Erosion

Fortification of Juices with Calcium Helps Decrease the Risk of Dental Erosion UTCAT2663, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Fortification of Juices with Calcium Helps Decrease the Risk of Dental Erosion Clinical Question In the adult population, does the fortification of calcium to fruit juice reduce enamel erosion as compared to those without calcium? Clinical Bottom Line Results show juices fortified (...) with a calcium compound have the potential to significantly lower the chances of enamel erosion compared to pure juices; however, more evidence is needed to support application clinically. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Scaramucci/2011 80 bovine enamel specimens in various solutions undergoing erosion, demineralization and remineralization. In vitro animal study Key results The specimens

2014 UTHSCSA Dental School CAT Library

137. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis (PubMed)

Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis We sought to evaluate the impact of coronary artery calcium (CAC) in individuals at the extremes of risk factor (RF) burden.6698 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA) were followed for coronary heart disease (CHD) events over mean 7.1 ± 1 years. Annualized CHD event rates were compared among (...) the absence of CAC, even among those with many RF, is associated with a low event rate. Coronary artery calcium has the potential to further risk stratify asymptomatic individuals at the extremes of RF burden.Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2013. For permissions please email: journals.permissions@oup.com.

Full Text available with Trip Pro

2014 EvidenceUpdates

139. Systematic review: Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour

Systematic review: Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour Article Text Therapeutics Systematic review Calcium channel

Full Text available with Trip Pro

2014 Evidence-Based Medicine (Requires free registration)

140. Cohort study: Calcium supplements associated with increased risk of cardiovascular death in men but not women

Cohort study: Calcium supplements associated with increased risk of cardiovascular death in men but not women Calcium supplements associated with increased risk of cardiovascular death in men but not women | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium supplements associated with increased risk of cardiovascular death in men but not women Article Text Primary health care Cohort study Calcium supplements associated with increased

2014 Evidence-Based Nursing